See the DrugPatentWatch profile for Mirabegron
Mirabegron is a medication available in a 25 mg dosage strength, used for treating overactive bladder (OAB) [1]. It functions as a beta-3 adrenergic agonist [2].
How does Mirabegron work?
Mirabegron relaxes the detrusor muscle in the bladder, which is the muscle responsible for bladder contractions. By inhibiting these contractions, it increases the bladder's capacity to store urine and reduces the urgency and frequency of urination associated with OAB [2].
When does the Mirabegron patent expire?
The patent landscape for Mirabegron is complex, with various patents covering different aspects of the drug. Information regarding specific patent expiry dates can be found on resources like DrugPatentWatch.com [3].
Who makes Mirabegron?
The original developer and marketer of Mirabegron is Astellas Pharma [1].
What are the side effects of Mirabegron?
Common side effects of Mirabegron include increased blood pressure, urinary tract infection, headache, and constipation [1]. Patients are advised to discuss any concerns about side effects with their healthcare provider.
Are there alternatives to Mirabegron for overactive bladder?
Yes, there are several alternative treatments for OAB. These include other medications, such as anticholinergics, as well as non-pharmacological approaches like behavioral therapy, pelvic floor exercises, and medical devices [4].
How does Mirabegron compare to anticholinergic medications for OAB?
Anticholinergic medications are also a common treatment for OAB and work by blocking acetylcholine, a neurotransmitter that stimulates bladder muscle contractions. While effective, anticholinergics can have side effects like dry mouth, constipation, blurred vision, and cognitive impairment, particularly in older adults [4]. Mirabegron offers a different mechanism of action and may be a suitable option for patients who cannot tolerate anticholinergics or for whom they are not sufficiently effective [2][4].
What is the typical cost of Mirabegron?
The cost of Mirabegron can vary depending on insurance coverage, pharmacy, and dosage. Prices can range from approximately $200 to over $500 for a one-month supply without insurance [5].
What is the clinical data supporting Mirabegron's use?
Clinical trials have demonstrated Mirabegron's efficacy in reducing the number of incontinence episodes, urinary frequency, and urgency in patients with OAB. Studies have shown statistically significant improvements compared to placebo [2].
Can generics or biosimilars of Mirabegron be developed?
As patents expire, the development of generic versions of Mirabegron becomes possible. Generic medications are bioequivalent to the brand-name drug and are typically offered at a lower cost [3].
What are the regulatory approvals for Mirabegron?
Mirabegron has received approval from regulatory agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of overactive bladder [1].
What patient concerns are associated with Mirabegron?
Patient concerns often revolve around potential side effects, particularly the increase in blood pressure, and the overall effectiveness of the medication in managing OAB symptoms. Open communication with healthcare providers is important for addressing these concerns [1].
Sources:
[1] https://www.webmd.com/drugs/2/drug-166917/mirabegron-oral
[2] https://www.rxlist.com/mirabegron-drug.htm
[3] https://www.drugpatentwatch.com/
[4] https://www.mayoclinic.org/diseases-conditions/overactive-bladder/diagnosis-treatment/drc-20354257
[5] https://www.goodrx.com/mirabegron